Toronto - Free Realtime Quote CAD
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
5.30
0.00
(0.00%)
As of May 13 at 4:00:00 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 8.04M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Direct | -- | Feb 17, 2025 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Direct | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.61 per share. | Direct | 1,044 | Sep 10, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 4,095 | Sep 4, 2024 |
| Montalbano (John S.) Director of Issuer | Acquisition or disposition in the public market at price 2.56 per share. | Direct | 37,873 | Jun 28, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.66 per share. | Direct | 2,926 | Jun 17, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.81 per share. | Direct | 2,248 | Jun 11, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 2,730 | Jun 7, 2024 |
Related Tickers
MSCL.TO Satellos Bioscience Inc.
0.6400
-4.48%
ENGNW enGene Holdings Inc.
0.6221
+1.98%
MDNA.TO Medicenna Therapeutics Corp.
1.0500
-4.55%
FRX.TO Fennec Pharmaceuticals Inc.
8.66
0.00%
ENGN enGene Holdings Inc.
3.1000
+7.64%
KNE.V Kane Biotech Inc.
0.0750
0.00%
RVX.TO Resverlogix Corp.
0.0400
-11.11%
NYMXF Nymox Pharmaceutical Corporation
0.0900
-0.22%
MBX.TO Microbix Biosystems Inc.
0.3600
0.00%
DNTH Dianthus Therapeutics, Inc.
18.66
-0.96%